Novavax Inc. diskutieren
Novavax Inc.
WKN: A2PKMZ / Symbol: NVAX / Name: Novavax / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,60 €
0,13 %
Sell Novavax Inc.
Buy Novavax Inc.
Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at B. Riley from $11.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at B. Riley from $29.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at JPMorgan Chase & Co. from $8.00 to $9.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $23.00 price target on the stock, down previously from $25.00.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $31.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $26.00 price target on the stock, up previously from $23.00.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at Jefferies Financial Group Inc. from $31.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $9.00 to $7.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for NVAX provided by MarketBeat
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $6.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) had its "underperform" rating reaffirmed by analysts at Bank of America Corporation. They now have a $7.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Acushnet Holdings Corp diskutieren